Squarepoint
WHWK

Squarepoint’s Whitehawk Therapeutics WHWK Stock Holding History

Squarepoint’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-83,660
Closed -$159K – 5047
2025
Q3 		$159K Buy
83,660
+22,294
+36% +$41K ﹤0.01% 4010
2025
Q2 		$115K Buy
+61,366
New +$107K ﹤0.01% 4137
2024
Q4 		– Sell
-10,510
Closed -$21.7K – 5591
2024
Q3 		$21.7K Sell
10,510
-10,120
-49% -$16.4K ﹤0.01% 4018
2024
Q2 		$30.1K Buy
+20,630
New +$38.2K ﹤0.01% 3943
2024
Q1 		– Sell
-46,164
Closed -$93.3K – 4723
2023
Q4 		$93.3K Buy
46,164
+22,565
+96% +$94.7K ﹤0.01% 3767
2023
Q3 		$114K Buy
23,599
+3,656
+18% +$21.3K ﹤0.01% 3542
2023
Q2 		$136K Sell
19,943
-838
-4% -$6.51K ﹤0.01% 3306
2023
Q1 		$150K Buy
+20,781
New +$222K ﹤0.01% 2890
2022
Q4 		– Sell
-16,317
Closed -$231K – 3684
2022
Q3 		$231K Buy
+16,317
New +$214K ﹤0.01% 2627
2022
Q2 		– Sell
-20,416
Closed -$346K – 3494
2022
Q1 		$346K Buy
+20,416
New +$391K ﹤0.01% 2194
2021
Q2 		– Sell
-1,135
Closed -$22K – 3781
2021
Q1 		$22K Buy
+1,135
New +$26.1K ﹤0.01% 3028

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Squarepoint's WHWK Position: Q4 2025 in Review

Squarepoint sold out of Whitehawk Therapeutics (WHWK) in Q4 2025, closing a stake of 83,660 shares — an estimated $159K sold.

Squarepoint first reported a position in WHWK in Q1 2021 and held it in 11 quarters. The position peaked at $346K in Q1 2022. 48 funds tracked by Wall St. Rank hold WHWK as of Q4 2025.

  • Squarepoint reported no remaining Whitehawk Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 83,660 Whitehawk Therapeutics shares in Q4 2025, an estimated $159K.
  • Squarepoint first reported a position in Whitehawk Therapeutics in Q1 2021 and held it in 11 quarters.
  • Squarepoint's Whitehawk Therapeutics position peaked at $346K in Q1 2022.
  • 48 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.